VivoSeq
Other

Enhanced Recovery

0

Pipeline Programs

6

Active Trials

0

Companies Involved

Enhanced Recovery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

15/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Recruiting4 · 31%
Completed4 · 31%
Unknown status1 · 8%
Terminated1 · 8%
Not yet recruiting1 · 8%
Withdrawn1 · 8%
Other1 · 8%

Trial Activity

13 trials

Enhanced Recovery After Urologic Surgery
Not yet recruiting··N/A·NCT06789744·150 enrolled
Towards Enhanced Recovery After Cesarean
Completed·UUniversity of Oklahoma·Phase 1·NCT04612920·33 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)